Latest News

rss

Latest News

In case you missed it. . .

Alzheimer’s vaccine at next stage of trials

A vaccine that represents an “interesting approach” to treating Alzheimer’s disease has reached the next stage of clinical trial.

ACI-24, developed by Swiss-based pharmaceutical company AC Immune, will be tested among people with a mild or moderate form of the condition.

The jab has progressed through Phase I trials, which examine the safety of a drug in a small group of people.

The Phase II trial is expected to be conducted in several European countries, including the UK, and the first person has been enrolled, AC Immune said.

“This is an interesting approach and with no treatments currently able to slow the progression of Alzheimer’s, it is important that researchers come at the disease from as many different angles as possible.”

ACI-24 is also being tested as a treatment for cognitive decline in people with Down’s syndrome, but trials are at an earlier stage.

Read More ...

(Source AgedCare Insite)



Comments are closed.


National Partners

 

 

About our Association

AAPM is a not-for-profit, national peak association recognised as the professional body dedicated to supporting effective Practice Management in the healthcare profession.

Get in touch

Communications

Not a member of AAPM but interested in news and events related to Practice Management? Subscribe to our mailing list to stay up to date!